国产a级特黄的片子,精品香蕉一区二区三区,亚洲精品99久久久久中文字幕,无码精品A∨在线观看无广告

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

无码国产激情在线观看| 国产精品毛片一区二区三区| 人妻av无码一区二区三区| 亚洲av永久无码精品网站| 丁香花视频在线观看| 国产三级精品三级| 国产+成+人+亚洲欧洲自| 人妻无码ΑV中文字幕久久琪琪布| a片在线播放| 香蕉欧美成人精品av在线| 日韩内射美女人妻一区二区三区 | 狠狠噜天天噜日日噜| 无码人妻丰满熟妇区bbbbxxxx | 国产亚洲精品精品精品| 人妻无码视频一区二区三区| 天堂在\/线中文在线资源| 人妻少妇伦在线无码| 丰满少妇被猛烈高清播放| 精品久久久久久亚洲中文字幕| 中文在线っと好きだっ最新版| 男男被一根又一根h强迫np| 久久午夜福利无码1000合集| 国内最真实的xxxx人伦| 日本公与熄乱理在线播放| 亚洲日韩精品一区二区三区无码| 精东影业传媒在线观看| 国产麻豆精品一区二区三区| 亚洲av无码日韩av无码网站冲| 欧美大屁股xxxx| 无码一区二区三区视频| 欧美性色黄大片a级毛片视频 | 99久久久无码国产精品免费砚床 | 9孩岁女精品╳片| 钙片gay男男gv在线观看| 国产精品无码AV片在线观看播| 亚无码乱人伦一区二区 | 丰满少妇a级毛片| 无码永久在线观看视频| 人人妻人人澡人人爽精品欧美 | 久久精品麻豆日日躁夜夜躁| 偷偷鲁2020精品偷拍视频|